Here, treatment with C16 plus Ang-1 upregulated p85 and p-AKT and suppressed the NF-κB/COX-2/TNF-α/IL-1β inflammatory pathway compared with the vehicle animals, implying that brain inflammation in AD possibly acts through activation of the PI3K/Akt pathway. Here, AKT1 is linked to Alzheimer disease.